Watch Ticker

Aquestive Therapeutics, Inc. Common Stock

Go to Aquestive Therapeutics, Inc. Common Stock Website

$3.36

(%)

Live

Previous Close

$3.36

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$302.3 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous Sys...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Analysts Estimate Aquestive Therapeutics (AQST) to Report a Decline in Earnings: What to Look Out for

Aquestive Therapeutics (AQST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Related tickers: AQST, ONCT.

Read Full Article

Aquestive Therapeutics, Inc. - Aquestive Therapeutics to Present Crossover Study Data for Libervant™ (diazepam) Buccal Film at 76th Annual Meeting of the American Academy of Neurology

WARREN, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (the “Company” or “Aquestive”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced a poster presentation highlighting the crossover study for the Company’s product candidate, Libervant™ (diazepam) Buccal Film for treatment of children with epilepsy aged two to five, will be presented at the 76th Annual Meeting of the American Academy of Neurology (AAN) in Denver from April 13 to 18, offering both in-person attendance and live online participation in a hybrid format.

Related tickers: AQST.

Read Full Article

Trending Tickers

DATS

XNAS

$1.25

(%)

LASE

XNAS

$1.94

(%)

BFRG

XNAS

$3.14

(%)

BMR

XNAS

$5.52

(%)

MLGO

XNAS

$0.00

(%)